Since 2004, NEA has funded innovative pilot projects that focus on issues important to the eczema community. Here’s a sampling of some of our key research projects and their findings.
Host-Mycobiome Interactions in Eczema and Atopic Dermatitis
Pranab K. Mukherjee, Ph.D.
Case Western Reserve University
Bleach Baths Normalize Skin Barrier Function, Diminish Th2 Inflammation and Improve Pruritus
The Efficacy of Meditation for Treatment of Chronic Pruritus: A Pilot Trial for Eczema Patients
Suephy C. Chen, M.D., MS
Crowdsourcing Eczema Social Media Conversations
Korey Capozza, MPH
Assessment of Autonomous Multisensory Intervention Device to Detect and Manage Night-time Pruritus Among Children with Atopic Dermatitis
Cheryl Riley-Doucet Ph.D., RN, and Hongwei Qu, Ph.D.
Oakland University, Rochester Hills, MI
Mental Health Comorbidity in Atopic Dermatitis
Eric Simpson, M.D., MCR
Oregon Health & Science University
Rodent Model of Atopic Dermatitis Associated with Itch Sensitization
Identifying Pathways that Enhance Epidermal Barrier Integrity as New Treatment Approaches for Atopic Dermatitis
Anna De Benedetto, M.D.
University of Rochester Medical Center
Genome-wide Analysis of Atopic Dermatitis
Patrick Brown, M.D. Ph.D., and Annika Saaf, Ph.D.
Beckman Center for Molecular and Genetic Medicine
Stanford University Medical Center
Topical Calcineurin Inhibitors for Atopic Dermatitis: Balancing Clinical Benefit and Possible Risks
Abrar A. Qureshi, M.D., MPH, and Michael A. Fisher, M.D., MS
Brigham and Women’s Hospital
Harvard Medical School
Do Alopecia Areata and Atopic Dermatitis Share HLA Alleles and Cytokine Profiles?
Nazila Barahmani, MD
MD Anderson Cancer Center
University of Texas
The Central Processing of Pruritus in Atopic Dermatitis using Arterial Spin Labeling Functional MRI
Gil Yospovitch, M.D. and Robert Coghill, Ph.D.
Wake Forest University
The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients
Gil Yospovitch, M.D., and Robert Coghill, Ph.D.
Wake Forest University
Why Subjects with Atopic Dermatitis (AD), as Compared to Non-Atopic, Healthy Controls, Have a Barrier Defect in the Skin That Makes Them More Susceptible to Skin Infections
Anna De Benedetto, M.D., and Lisa A. Beck, M.D.
Department of Dermatology
University of Rochester
Cathelicidin Antimicrobial Peptides Influence Mast Cell Granule Composition and Release: Control of Itch by the Innate Immune System
Anna Di Nardo, M.D., Ph.D.
University of California, San Diego